STAGE IV GALLBLADDER CANCER AJCC V8
Clinical trials for STAGE IV GALLBLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV GALLBLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV GALLBLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat against tough cancers: drug combo plus radiation shows promise
Disease control OngoingThis study tests a new combination of two drugs (peposertib and avelumab) plus a special type of radiation for people with advanced solid tumors or bile duct cancers that have spread. The goal is to find the safest dose and see if the treatment can shrink tumors. About 103 adults…
Matched conditions: STAGE IV GALLBLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug cocktail shows promise for Tough-to-Treat biliary cancers
Disease control OngoingThis study tests whether adding the targeted drug binimetinib to standard chemotherapy (mFOLFOX6) can shrink tumors or improve survival in people with advanced biliary tract cancers (bile duct or gallbladder) that have specific genetic changes (MAPK pathway mutations). About 66 a…
Matched conditions: STAGE IV GALLBLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:42 UTC